Molecular Biology of Polycythemia and Thrombocytosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity of Utah
About this trial
Our study is designed to characterize the clinical picture and genetic pattern of Polycythemia and Thrombocytosis. The purpose of this project is to find a gene and its mutation that causes these disorders. When this is accomplished, new therapies to control and eventually cure the disorder can be designed.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Subjects with an elevated hemoglobin concentration (>18 in males and >16 in females)
Subjects with an elevated platelet count (>450,000)
Disqualifiers
Subjects who have a known acquired cause of polycythemia and thrombocytosis
Subjects with heart disease, left to right heart shunt or severe pulmonary disease
Trial population
Subjects who have polycythemia and thrombocytosis will be included in the study.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
200 Participants
are grouped into 1 trial groupGroup A: Affected Population
Trial outcomes
Primary outcomes
1
Identify the molecular defect of Polycythemic and Thrombocythemic disorders
Time frame
WeeklySponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Utah
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
Source ClinicalTrials.gov